Full-Time

Lead Software Engineer / Tech Lead Manager

Growth

Maximus Health

Maximus Health

51-200 employees

Subscription-based testosterone optimization with clinicians

Compensation Overview

$150k - $200k/yr

+ Equity Grants

Toronto, ON, Canada + 1 more

More locations: Vancouver, BC, Canada

Remote

Category
Software Engineering (1)
Required Skills
Amplitude
Python
JavaScript
React.js
Ruby
Requirements
  • You've led a team of 4-8 engineers before, with direct reports you grew and retained
  • You've shipped and measured growth experiments in a subscription product (signup funnels, checkout optimization, pricing and plan architecture)
  • You write production Ruby on Rails and React code and expect to keep doing so (strongly preferred). Javascript (Node), Python are also acceptable
  • You can design an experiment, pick the right metric, set a sample size, and explain the trade-offs to a PM who wants to ship faster
  • You think in funnels and cohorts, not just features
  • You're comfortable with event-sourced systems or similar architectural patterns where state is derived from event streams
  • You use agentic AI coding tools (Claude Code, Devin, Cursor, or similar) in your daily workflow and have opinions about how to integrate them into a team's development process
Responsibilities
  • Deliver protocol-level A/B experiments on signup flows, checkout, plan pricing, and product recommendations using Amplitude
  • Ship full-stack features across the acquisition funnel in Rails and React
  • Coach and develop your engineering team through regular 1:1s, pair programming, code reviews, and career conversations
  • Own experiment design, including sample sizing, metric selection, and the CVR-vs-retention tension that comes with a dual mandate
  • Iterate and continuously optimize plan and pricing architecture, including payment platform integrations
  • Build and maintain the experimentation infrastructure your team runs on
  • Partner with data engineering to instrument cohort-level M1 retention tracking per experiment
  • Drive adoption of AI-assisted development across the team, using tools like Claude Code and Devin to increase shipping and development velocity
Desired Qualifications
  • Experience with healthcare, wellness, or regulated subscription commerce
  • Familiarity with Stripe billing, Klarna, or similar payment platform integrations
  • Experience building or managing Amplitude (or LaunchDarkly, Optimizely, etc.) experimentation infrastructure

Maximus Health offers testosterone optimization for adult men experiencing low energy, motivation, and sex drive. It operates a subscription-based program built around the King Protocol, which combines prescribed testosterone-related medication with ongoing clinician support and monthly follow-ups to monitor progress. Treatments are guided by input from urology and endocrinology specialists and medical advisors to ensure safety and efficacy. The service provides continuous medical care and medication through a monthly fee, with the aim of improving energy, motivation, sexual health, and overall well-being so men can reach their full potential.

Company Size

51-200

Company Stage

Series A

Total Funding

$20M

Headquarters

Santa Monica, California

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • $15M Series A led by Keith Rabois fuels expansion into GLP-1 weight loss.
  • Client testimonials show 2.8X testosterone boost enhancing energy and focus.
  • Endocrinology experts ensure protocol safety and efficacy for men's performance.

What critics are saying

  • Hims & Hers bundles steal subscribers with cheaper TRT and ED treatments.
  • PeterMD's $99/month enclomiphene undercuts Maximus's premium subscriptions.
  • Ro Body's AI triage and wearables outpace static monthly clinician follow-ups.

What makes Maximus Health unique

  • King Protocol delivers 2-3X testosterone increases in 2-4 weeks via enclomiphene.
  • Tasso+ shoulder lancet enables pain-free at-home blood draws unlike finger-pricks.
  • hCG adjunct supports steroid recovery and periodic TRT injection suspensions.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Maximus Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Flexible Vacation/Time-off policies

Remote Work Options

401(k) Best-in-class options

401(k) Retirement Plan

Full Suite: Medical, Dental, Vision, Life Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Wellness Program

Mental Health Support

Flexible Work Hours

Stock Options

Extended options exercise window for loyal employees (3 months for every year of service; e.g. 1 year for 4+ year employees)

Company News

The Manila Times
Apr 3rd, 2026
Maximus ranked #7 on the Financial Times' list of The Americas' Fastest Growing Companies 2026.

Maximus ranked #7 on the Financial Times' list of The Americas' Fastest Growing Companies 2026. By GlobeNewswire April 4, 2026 Santa Monica, CA, April 03, 2026 (GLOBE NEWSWIRE) - Maximus (maximustribe.com), the performance medicine telehealth company, today announced it has been named #7 on the Financial Times list of The Americas' Fastest Growing Companies 2026. This award is presented by the Financial Times and Statista Inc., a leading statistics portal and industry ranking provider. The full ranking was published today on FT.com. The Americas' Fastest Growing Companies 2026 ranking identifies the top 500 companies across North and South America that have achieved the highest compound annual growth in revenues between 2021 and 2024. Maximus's #7 placement puts it among an elite tier of the fastest-scaling businesses in the Western Hemisphere, and the second highest-ranked telehealth company on the list. Founded in 2020, Maximus is a performance medicine company that combines cutting-edge clinical science, board-certified physicians, and personalized treatment protocols-all delivered through a 100% online telehealth platform. The company originally launched with its proprietary, patented testosterone optimization protocols. Since then, Maximus has expanded into GLP-1 weight loss treatments, hair regrowth, their patent-pending Oxytocin Calming Cream, and most recently, a new generation of peptide therapies including growth hormone releasing hormones (GHRHs). This growth reflects the rapid expansion of performance medicine as a category within American healthcare. Unlike traditional sick-care models that treat symptoms reactively, performance medicine focuses on optimizing health outcomes proactively by improving hormone levels, metabolic function, and overall physical performance in people who refuse to settle for average health. The direct-to-consumer telehealth model has proven to be a powerful delivery mechanism for this category, eliminating the access barriers and long wait times that have historically kept performance-focused treatments confined to concierge medicine practices. "Being recognized as the #7 fastest growing company in the Americas is a direct reflection of the demand for what we're building," said Dr. Cameron Sepah, Founder and CEO of Maximus. "Millions of people know they can perform better-physically, mentally, and professionally-but the traditional healthcare system wasn't built to help them get there. We built Maximus to fill that gap: world-class clinical protocols, real physician oversight, and the convenience of a fully online experience. Our expansion from testosterone optimization into weight loss and now peptide therapies like GHRHs shows that when you give people access to safe, effective performance medicine, the demand is enormous." Maximus is backed by Founders Fund and 8VC, two of the most prominent venture capital firms in technology and healthcare investing. The company's sustained revenue growth from 2021 through 2024 demonstrates a durable business model built on strong client retention, expanding treatment protocols, and a growing base of clients who trust Maximus with their ongoing health optimization. Dr. Sepah added: "Our mission has always been to help people transcend their potential-to look, feel, and perform at their absolute peak. This ranking validates that the market for performance medicine is real, it's growing fast, and Maximus is leading it. We're just getting started." Statista publishes hundreds of global industry rankings and company listings in collaboration with high-profile media partners. This research and analysis service builds on the success of statista.com, a leading data and business intelligence platform providing statistics, market data, and consumer insights. About Maximus Maximus is a performance medicine telehealth company that helps people optimize their hormones, metabolism, and overall health through doctor-supervised, evidence-based protocols delivered entirely online. Founded in 2020 by Dr. Cameron Sepah, a Harvard-educated clinical psychologist and former Assistant Clinical Professor of Psychiatry at the UCSF School of Medicine, Maximus offers proprietary treatment protocols across testosterone optimization, GLP-1 weight loss, peptide therapies, and clinical-grade supplements. Every treatment plan is designed and overseen by board-certified, U.S.-based physicians. Maximus is backed by Founders Fund and 8VC. Learn more at maximustribe.com. Press Inquiries John Sheldon press [at] maximustribe.com 3415 S Sepulveda Blvd #1250 Los Angeles, CA 90034

Business Wire
Aug 10th, 2022
Maximus Raises $15M To Optimize Men’S Health Hormones Using Cutting-Edge Medicine

LOS ANGELES--(BUSINESS WIRE)--While the world is striving to solve the COVID pandemic, it is waking up to a problem that’s just as big: the hormone pandemic. Testosterone levels and sperm counts have dropped approximately 50% in the last 50 years, and a cutting-edge technology startup has risen to help men restore their vitality and masculinity. Maximus (maximustribe.com) is a Los Angeles-based consumer telemedicine company that provides at-home lab testing and doctor-prescribed protocols to optimize men’s health and hormone function, and has raised $15 million in venture financing, including its latest Series A funding round. Led by Keith Rabois at Founders Fund, other investors include 8VC, Abstract Ventures, 10X Capital, Unshackled Ventures, OneVC, Gaingels, Correlation Ventures, Chamaeleon VC, Rational Ventures, WhatIf Ventures, Shrug Capital, Electric Ant, and operators/angel investors including Dave Asprey (Bulletproof), Ryan Holiday (Daily Stoic), Brain Lee (The Honest Company), Jeff Weiser (L Catterton), Brian Nogard (ex-Tinder), Kyle Samani (Multicoin Capital), Matteo Franceschetti (Eight Sleep), & Geoffrey Wu (HVMN)